Sort
30,917 grants matching “tumor microenvironment”
Targeting the immunosuppressive adenosine-axis to overcome T-cell γc cytokine signaling blockade and enhance antitumor immunity in hepatocellular carcinoma
$378,246Yong Qin · University Of Texas El Paso · U54 · FY2025 · MD
Targeting the liver for immunotherapy in pancreatic cancer
$378,219Gregory L Beatty · University Of Pennsylvania · R01 · FY2023 · CA
Function of the Ras Related Ral Protein
$378,207Larry Feig · Tufts University Boston · R01 · FY2013 · GM
The role of fibroblasts in the activities of tissue penetrating peptides
$378,202Kazuki Sugahara · Columbia University Health Sciences · R01 · FY2016 · CA
The role of fibroblasts in the activities of tissue penetrating peptides
$378,202Kazuki Sugahara · Columbia University Health Sciences · R01 · FY2015 · CA
USP18 in Cancer Development
$378,186Dong-Er Zhang · University Of California, San Diego · R01 · FY2021 · CA
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
$378,171Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
$378,171Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
UCSC-Buck Genome Data Analysis Center for the Genomic Data Analysis Network v2.0
$378,154Joshua Michael Stuart · University Of California Santa Cruz · U24 · FY2022 · CA
Regulation of B cells in the CNS
$378,154Cornelia C Bergmann · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · NS
Nanoparticle delivery of miRNA-based therapeutics to overcome clinical challenges in triple negative breast cancer
$378,124Zhihui Wang · Methodist Hospital Research Institute · R01 · FY2024 · CA
Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer
$378,030Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2021 · CA
Drug-Loaded Nanobubbles for Ultrasound Enhanced Delivery to Colon Cancer Liver Metastasis
$378,024Agata A Exner · Case Western Reserve University · R01 · FY2020 · EB
Project 3: Localized microneedle-directed combination immunotherapy for cSCC
$378,023Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
Project 2: Immunotherapy with CMP-001 intratumoral and nivolumab in melanoma
$378,023Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
$378,022Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
Imaging of Stromal Cells in the Tumor Microenvironment
$378,005Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2008 · CA
The B7x pathways in the tumor microenvironment
$378,000Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Effects of common polymorphisms in immune sensors in tumor immunosurveillance
$377,972Jose R Conejo-Garcia · Wistar Institute · R01 · FY2015 · CA
Transcriptional Regulation of Dormancy and Emergence in Breast Cancer
$377,929Partha Roy · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER
$377,922Don X Nguyen · Yale University · R01 · FY2024 · CA
INTEGRIN SIGNALING DURING BREAST TUMORIGENESIS
$377,912Filippo G Giancotti · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Dual orthogonal fluorescent protease sensors for image guided surgery
$377,899Matthew S Bogyo · Stanford University · R01 · FY2023 · EB
Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
$377,877Renato V. Iozzo · Thomas Jefferson University · R01 · FY2023 · CA
Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
$377,877Renato V. Iozzo · Thomas Jefferson University · R01 · FY2022 · CA